Autotacbio (AUTOTAC Bio) is a biotechnology company developing first‑in‑class therapeutics based on its proprietary AUTOTAC (Autophagy‑Targeting Chimera) platform. The company focuses on targeted protein degradation to treat neurodegenerative diseases, cancer, metabolic disorders, and other conditions by directing disease‑causing proteins to autophagy for lysosomal clearance. It operates from Seoul, Korea, and aims to become a global pharmaceutical leader.
Autotacbio is profiled on the APIs.io network. Tagged areas include Biotechnology, Protein Degradation, Therapeutics, South Korea, and AUTOTAC.
Regulatory Posture applies to this provider. Its tags matched the
Horizontal (data, software, accessibility, platform) regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Show this score on your site.
It updates itself when the score changes. Paste this where you link to your API docs:
<a href="https://apis.io/providers/autotacbio/"><img src="https://apis.io/badge/autotacbio/card.svg" alt="Autotacbio on APIs.io — Kin Score by API Evangelist"></a>
Other styles, a README pill and a shields.io endpoint are on the badge page.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/autotacbio: open an issue to ask a question, or submit a pull request to add artifacts.
Submit an artifact on GitHub — free →Manage your own listing — the Influence plan, $499/mo →
aid: autotacbio
name: Autotacbio
description: Autotacbio (AUTOTAC Bio) is a biotechnology company developing first‑in‑class therapeutics based on its proprietary
AUTOTAC (Autophagy‑Targeting Chimera) platform. The company focuses on targeted protein degradation to treat neurodegenerative
diseases, cancer, metabolic disorders, and other conditions by directing disease‑causing proteins to autophagy for lysosomal
clearance. It operates from Seoul, Korea, and aims to become a global pharmaceutical leader.
url: https://raw.githubusercontent.com/api-evangelist/autotacbio/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment pass 2026-09-26 (modular-v1; was harvest)
specificationVersion: '0.20'
created: '2026-09-26'
modified: '2026-09-26'
tags:
- Biotechnology
- Protein Degradation
- Therapeutics
- South Korea
- AUTOTAC
tags_raw:
- Biotechnology
- Protein Degradation
- Therapeutics
- Korea
- AUTOTAC
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Hosts
url: hosts/autotacbio-hosts.yml
- type: DomainSecurity
url: security/autotacbio-domain-security.yml
- type: Website
url: http://www.autotacbio.com
apis: []
x-coverage:
state: none
reason: no-developer-program
detail: The site provides no developer documentation or API information.
evidence:
- url: http://www.autotacbio.com
status: 200
checked: 2026-09-26
x-enrichment:
date: '2026-09-26'
status: enriched
artifacts_added: 5
pass: modular-v1
engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.